Andrea Pagan
Gastroenterology · Port Orange, FLNPI 1013428549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 34.0% of the total. 2025 is the largest year on record at $2,223, 3.8 times the $590 reported in 2022.
Across 146 payments — averaging $29.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Madrigal Pharmaceuticals$331
- Medtronic$318
- Takeda Pharmaceuticals U.S.A., Inc.$269
- Johnson & Johnson$245
- Sanofi$228
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,327100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $1,476 |
| Madrigal Pharmaceuticals | 14 | $331 |
| Medtronic | 2 | $318 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $269 |
| Johnson & Johnson | 23 | $245 |
| Sanofi | 7 | $228 |
| Ardelyx, Inc. | 3 | $227 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $187 |
| QOL Medical, LLC | 6 | $175 |
| Mallinckrodt Hospital Products Inc. | 1 | $134 |
| Intercept Pharmaceuticals, Inc. | 3 | $131 |
| Phathom Pharmaceuticals, Inc. | 1 | $117 |
| Ipsen Biopharmaceuticals, Inc | 4 | $100 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Celltrion USA Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Enterra Medical, Inc. | 1 | $30 |
| Novo Nordisk | 1 | $24 |
| Gilead | 1 | $21 |
| Pfizer | 1 | $20 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,347 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 16 | $1,057 |
| Omeprazole | 13 | $402 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 23 | $389 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Port Orange
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.